Clinical significance and management of ventricular arrhythmias in heart failure

Area of Science:

• Cardiology
• Electrophysiology

Background:

• Ventricular arrhythmias are common in heart failure, a leading cause of sudden cardiac death.
• Heart failure progression and sudden death share overlapping mortality causes.
• Advanced diagnostic techniques beyond traditional ECG are being explored.

Purpose of the Study:

• To evaluate the diagnostic and prognostic utility of newer techniques for ventricular arrhythmias in heart failure.
• To assess the effectiveness and risks of antiarrhythmic drugs in heart failure patients with varying degrees of left ventricular dysfunction.

Main Methods:

• Review of signal-averaged ECG for late potentials in dilated cardiomyopathy.
• Analysis of heart period variability in relation to mortality.
• Evaluation of programmed ventricular stimulation in heart failure and coronary artery disease versus dilated cardiomyopathy.
• Assessment of antiarrhythmic drug efficacy and adverse effects based on heart failure severity.

Main Results:

• Signal-averaged ECG utility is not clearly established in dilated cardiomyopathy.
• Heart period variability correlates with overall mortality but not specific mechanisms.
• Programmed ventricular stimulation is useful in coronary artery disease-related heart failure but questionable in dilated cardiomyopathy.
• Antiarrhythmic drug efficacy decreases with worsening left ventricular dysfunction and increases adverse effects (negative inotropic, proarrhythmic, bradyarrhythmic) with heart failure progression.

Conclusions:

• Current diagnostic tools have limitations in specific heart failure populations like dilated cardiomyopathy.
• Antiarrhythmic drug therapy in heart failure is complex, with reduced efficacy and increased risks at higher heart failure severity.
• Ongoing trials are investigating amiodarone for antiarrhythmic treatment in heart failure.